Newly listed N Lianya jumped 285.71% on debut. Public filings show the company
develops, manufactures and sells complex drug formulations—including various
controlled/extended‑release products and low‑dose high‑end generics—used in
hypertension, coronary heart disease, diabetes, schizophrenia, contraception and
health products.